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Cryopreservation describes techniques that permit freezing and subsequent warming of biological 24 
samples without loss of viability. The application of cryopreservation in assisted reproductive 25 
technology encompasses the freezing of gametes, embryos and primordial germ cells. Whilst some 26 
protocols still rely on slow-freezing techniques, most now use vitrification, or ultra-rapid freezing, for 27 
both oocytes and embryos due to an associated decreased risk of damage caused by the lack of ice 28 
crystal formation, unlike in slow-freezing techniques. Vitrification has demonstrated its use in many 29 
applications, not only following in vitro fertilisation (IVF) procedures in human embryology clinics, but 30 
also following in vitro production (IVP) of embryos in agriculturally important, or endangered animal 31 
species, prior to embryo transfer. Here we review the various cryopreservation and vitrification 32 
technologies that are used in both humans and other animals and discuss the most recent innovations 33 
in vitrification with a particular emphasis on their applicability to animal embryology. 34 
 35 




Over the last few decades, cryopreservation techniques have progressed rapidly. This progress has 40 
made a significant impact in many fields, with reproductive medicine possibly the most significant. 41 
From initial success in cryopreservation of sperm [1], it is now routinely used for the preservation of 42 
oocytes, sperm and embryos within both agricultural systems and in assisted reproductive technology 43 
(ART) in humans. Cryopreservation is a process by which biological cells or tissues are preserved at 44 
sub-zero temperatures resulting in a radical decrease in the rate of metabolic processes and the ability 45 
to store samples for extended periods [2]. However, as would be expected, freezing cells causes 46 
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damage and this must be circumvented. The two major causes of cellular damage are the physical 47 
damage caused by the formation of ice crystals and the chemical damage that results from changes in 48 
intracellular solute concentrations. Both of these damage types can be avoided, or at least 49 
ameliorated, by controlling how the temperature is reduced and by modifying the cellular conditions. 50 
For instance, the mechanical damage that results from the piercing action of ice crystals can be 51 
avoided by making the freezing process very rapid and the significant rise in intracellular solute 52 
concentration as the formation of ice crystals increases can be avoided by use of cryoprotectants [3]. 53 
Permeating cryoprotectants replace intracellular liquid and decrease ice formation [4]; as such they 54 
need to have low toxicity, be capable of penetrating cells and be able to withstand extremely low 55 
temperatures. Examples of commonly used cryoprotectants include glycerol, ethanediol, dimethyl 56 
sulphoxide (DMSO), ethylene glycol (EG) and propanediol [5]. Whilst most cells cannot survive the 57 
freezing process without use of a cryoprotectant, it is also important to note that simply using such 58 
solutions alone is insufficient for cell survival after freezing (and thawing); survival also depends on 59 
the cell type and its ability to withstand various stresses caused by physical and physiochemical 60 
changes during the process, as well as rates of cooling and warming [5]. 61 
 62 
The promise of vitrification 63 
Vitrification eradicates damage caused due to ice crystal formation during the cooling process. The 64 
method involves rapid cooling and liquid solidification due to a substantial rise in viscosity and results 65 
in the formation of a solid glass-like form [6]. This solid ‘glassy’ layer is amorphous; meaning that it 66 
can readjust and take the shape of the cell, hence enabling the cell to maintain its structure and remain 67 
intact, unlike in slow-freezing, where the formation of ice crystals during cooling prevents the cell from 68 
maintaining its structure. See Figure 1 for a schematic comparison of slow-freezing and vitrification. 69 
There have been a number of studies that have compared  slow-freezing techniques and vitrification 70 
in human embryology [7][8]; whilst it seems that there is a gradual move towards more widespread 71 
use of vitrification clinically, the literature to date describes no consensus as to which method is the 72 
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best. For example, Herrero and colleagues established that cryopreservation of both human oocytes 73 
and blastocysts demonstrate competitive pregnancy rates when compared to those obtained through 74 
implantation of fresh samples and that vitrification was preferable in terms of minimised cellular 75 
damage and higher post-warming survival rates when compared to traditional freezing processes 76 
[9][10]. Whilst some still opt for a traditional slow-cooling method via the use of insemination straws, 77 
others now use fast-cooling vitrification techniques, employing an array of different vitrification 78 
systems including; thin capillaries or straws, Cryotop, Cryoloop, Cryolock, CryoTip, nylon mesh, plastic 79 
blades, Vitri-ingá, electron microscopic grid, Gavi and the minimum drop size technique [11]. For 80 
example, Kuwayama (2007) discusses the efficiency of the Cryotop method, wherein he states that 81 
cryopreservation of blastocysts using the Cryotop method resulted in more live births when compared 82 
to any other vitrification system [12]. Moreover, Mukaida and colleagues used clinical results from 83 
725 human blastocysts (of which 80.4% survived vitrification and warming) to establish that the 84 
Cryoloop system can be used as an effective method for vitrification of human blastocysts [13]. 85 
Additionally, Sugiyama et al. (2010) tested the effect of a plastic blade as a cryopreservation device 86 
on survival rates of human embryos and blastocysts following vitrification and warming. Interestingly, 87 
this demonstrated that whilst 98.4% of cleavage stage embryos survived vitrification and subsequent 88 
warming, all of the blastocysts survived [14]. In a comparative study, Desai and colleagues 89 
comparatively assessed three cryo-devices on the impact of vitrification (nylon mesh, micro-capillary 90 
tips and an electron microscopy grid), of murine pre-antral follicles and found no significant 91 
differences for subsequent in vitro development following vitrification. However, a low survival rate 92 
was observed for follicles vitrified using micro-capillary tips, and it was revealed that when a large 93 
number of follicles required vitrification, a nylon-mesh was most successful [15]. In 2008, Vitri-ingá, 94 
was developed and tested on bovine oocytes; the device showed promising results with an 86% 95 
survival rate post warming [16]. The method was subsequently adapted for use with human oocytes 96 
and in 2010, Almodin and colleagues evaluated the device’s success, by comparing gestational results 97 
achieved via use of frozen-warmed human oocytes vitrified using Vitri-ingá and by those that did not 98 
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undergo vitrification. The technology was tested clinically on 125 human patients, of which 79 patients 99 
received embryos that were derived from fresh oocytes, while 46 patients were implanted with 100 
embryos that were developed using frozen-warmed oocytes vitrified by Vitri-ingá technology; a high 101 
survival rate of 84.9% was demonstrated by oocytes that underwent vitrification. Moreover, no 102 
significant differences were reported for fertilisation, implantation or pregnancy rates between the 103 
patients of the two groups [17]. Successes of vitrification methods have resulted in IVF clinics around 104 
the world progressively shifting away from traditional slow-freezing methods for routine use in ART 105 
[18][19]. As is evident here, new vitrification techniques are constantly being developed and these can 106 
be broadly classified as open or closed – the distinction depending on the degree to which there is, or 107 
is not, direct contact between the media and the liquid nitrogen used during the cooling process.  108 
 109 
Open and closed vitrification systems: a comparison 110 
In an open system, the oocytes or embryos come into direct contact with liquid nitrogen, whereas in 111 
a closed system, they do not. Direct comparisons between these types of systems have been limited; 112 
however, the available evidence suggests that the viability of oocytes and embryos post-warming can 113 
be similar. For instance, Papatheodorou and colleagues compared open and closed systems by 114 
conducting a randomised trial using human sibling oocytes. Whilst survival rates following vitrification 115 
using the closed system (82.9%) were slightly lower than that of the open system (91.0%), there was 116 
no significant effect on observed, clinical, or ongoing pregnancies between the two groups. Moreover, 117 
the closed system group produced higher live birth rates as well as a higher number of healthy babies 118 
(27 versus 18) [20]. Researchers in Tokyo demonstrated similar findings, showing no significant 119 
difference between blastocyst survival rates using the CryoTip™ (closed system) and the Cryotop 120 
(available as either an open or closed carrier system) [21]. Comparisons were also made between 121 
slow-freezing and ultra-rapid vitrification of human embryos, which indicated that vitrification was 122 
the most reliable; these results are summarised in Table 1. Similarly, comparisons between Rapid-i® 123 
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and Cryotop [22], and between Vit Kit Freeze/Thaw (Irvine Scientific, CA) Global Fast Freeze/Thaw Kits 124 
(LifeGlobal, Canada) [23] indicate that these systems can produce comparable results.  125 
 126 
Interestingly, conflicting evidence by Paffoni et al. (2011) revealed considerably lower pregnancy rates 127 
and a higher ratio of cancelled cycles for vitrification of mature human oocytes using a closed system, 128 
as opposed to an open system [24]. Moreover, when embryological parameters were compared for 129 
sibling oocytes that were either fresh or vitrified using the closed system, fertilisation rates and 130 
cleavage rates were considerably lower for those that underwent vitrification in an open system. The 131 
closed system vitrified oocytes also produced embryos of a lower standard, when compared to their 132 
fresh sibling oocytes, in terms of both quantity and quality. However, when the same parameters were 133 
compared between oocytes that were vitrified using the open system and their fresh sibling 134 
counterparts, no significant differences were observed. Though these observations could, most likely, 135 
be due to variation in sensitivities between oocytes and blastocysts, this study suggests that an open 136 
vitrification system is more reliable than a closed system [24].  As this indicates, the evidence in the 137 
literature when comparing open and closed vitrification systems is conflicting. Another important 138 
consideration is the potential contamination of samples during the cooling process. Whilst there is 139 
currently no clinical evidence of pathogenic contamination during cryopreservation of oocytes and 140 
embryos specifically [25], there has been some evidence to show contamination of other types of 141 
human tissue, such as bone marrow, through liquid nitrogen during cryopreservation [26]. It has also 142 
been noted that slow cooling by the use of static vapour freezers reduces the risk of pathogenic 143 
contamination, unlike with use of open vitrification methods in which samples come into direct 144 
contact with liquid nitrogen [27]. Closed vitrification however is considered to be aseptic due to the 145 
elimination of the potential for pathogen contamination from liquid nitrogen [28] and for this reason 146 
closed systems could be regarded as preferable for use in vitrification. Bielanski and Vajta (2009) 147 
discuss concerns regarding sterility of liquid nitrogen in ARTs, and it seems that to date, even though 148 
methods exist to produce sterile liquid nitrogen, no commercial provider exists [27]. Another, 149 
7 
 
relatively new vitrification device, Gavi (Genea Biomedx) permits the process to be further 150 
standardised and automated. The device comprises of a thin walled pod that allows for rapid 151 
vitrification and warming rates; the pod also incorporates a microfluidic design in order to maintain 152 
the embryo’s location thereby permitting automated exchange of fluids. Finally, the instrument 153 
automatically seals the pods, which, unlike the manual Cryotop method or in other existing open 154 
vitrification technologies, eradicates the risk of pathogenic contamination from liquid nitrogen by 155 
confirming that the pod is completely closed [10]. Results to date demonstrate that mouse (zygotes, 156 
cleavage stage embryos and blastocysts) and human (vitrified-warmed blastocysts) vitrified samples 157 
using the Gavi technology produced similar results to those of the control samples which were vitrified 158 
using the manual Cryotop method that is currently considered to be the gold standard for vitrification 159 
[10].  160 
 161 
As is evident from the literature, both open and closed vitrification systems are now used clinically for 162 
cryopreservation of human oocytes and embryos; further to this, a number of studies (discussed later) 163 
have also been executed in other species.   164 
 165 
The mouse as a model  166 
In some cases, the vitrification of non-human oocytes and embryos can be particularly challenging, 167 
such as is the case in the pig model; these challenges are discussed later, in addition to a discussion 168 
pertaining to oocyte and embryo vitrification of other important agricultural species. The mouse (Mus 169 
musculus) is a particularly powerful model for studying mammalian embryo development due to 170 
broad morphological similarities [29]. The extensive genome similarities between mouse and human 171 
coupled with the experimental tractability of the mouse also provide significant benefits to using this 172 
species. Additionally, mouse embryos are also more readily available than those of many 173 
agriculturally-important animal species [30]. As such, it is unsurprising that numerous experiments 174 
have been conducted on cryopreservation of murine oocytes, embryos and ovaries. Similarly to the 175 
8 
 
case for humans, comparative studies have demonstrated that vitrification of murine oocytes 176 
[15][31][32][33][34][35] and embryos at blastocyst stage [36][37] results in higher post-warming 177 
survival rates, fertilisation, and better subsequent in vitro embryonic development than conventional 178 
slow-freezing techniques. Similar findings based on vitrification of murine ovarian tissue indicates that 179 
cryopreservation of mouse ovaries can be used to preserve fertility, as well as endocrine functions of 180 
ovaries, an approach that has been implemented in human models [38][39][40]. Mice have also been 181 
used to develop (and test) novel vitrification devices. For example, using murine blastocysts, Kong and 182 
colleagues demonstrated that an open pulled straw and a glass micropipette could be used 183 
independently as vitrification vessels to obtain high embryo survival rates [41]. Similarly, in a more 184 
recent study, a new, simplified technique, ‘needle immersed vitrification’, was developed as a 185 
vitrification approach for preservation of ovarian tissue in mice [42]. One of the key benefits of this 186 
method is that the technique, which can also be used to vitrify human ovarian tissue, uses a minimal 187 
volume of cryoprotectants at a low concentration, thereby resulting in lower toxicity of vitrification 188 
solutions, hence resulting in less cellular-damage [42]. 189 
 190 
Embryology and vitrification progress in agricultural animals 191 
Human ART procedures are now used clinically worldwide and such methods give families the chance 192 
to have healthy offspring, which in many cases would not have been possible before such advances. 193 
The ‘one child at a time’ report, published by the Human Fertilisation and Embryology Authority 194 
(HFEA) in 2006 [43], aimed to reduce the incidence of multiple births following ART; however, the 195 
challenges associated with agricultural animal IVF are somewhat different; procedures developed for 196 
humans need to be adapted and scalable for a far larger number of viable embryos to be produced. 197 
Additionally, the 100% success rate that is strived for in human IVF is perhaps not such an important 198 
consideration in other animal IVF, especially considering the quantity of embryos that are required in 199 
comparison. There is increasing interest within agricultural breeding communities to cryopreserve 200 
oocytes and embryos of agriculturally important animals such as pig, cow and sheep [44][30]. Both 201 
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the domestic pig (Sus scrofa domesticus) and cattle (Bos taurus) are of significant importance for meat 202 
(and milk) production. The United Nations suggests that the world population is predicted to grow to 203 
a projected 9.15 billion by 2050 [45]; and it has been indicated that the consumption of meat is 204 
expected to rise in order to supply the 20% increase in per capita calorific intake. Not only this, but it 205 
is current practice to transport live animals that are either genetically ‘superior’ or that are better to 206 
matched to particular markets between countries. The transportation of live animals is both expensive 207 
and logistically demanding, and hence the prospect of transporting frozen embryos as opposed to live 208 
animals is an attractive one [46][47]. Not only would the ability to transport vitrified (and viable) 209 
embryos be an approach that would be more practical and cost effective, but it would also minimise 210 
the risk of disease transmission both within and between species [48]. In addition, routinely used 211 
techniques in human embryology, such as preimplantation genetic diagnosis (PGD) and sex 212 
determination techniques, could be usefully adapted for both pig and cow species. This could facilitate 213 
in vitro production (IVP) of viable embryos that are predominantly female, which again, would be 214 
economically favourable to agricultural breeding companies [49]. Moreover, it is important to note 215 
that the challenges faced in animal embryo vitrification and warming (particularly in livestock species) 216 
are somewhat different when compared to those faced in human IVF clinics; warming protocols may 217 
need to be performed on farm which would inherently increase the risk of potential pathogenic 218 
contamination [50]. Furthermore, existing vitrification protocols would need to be adapted for a large 219 
number of viable embryos.    220 
 221 
In comparison to mice, numerous studies have revealed that freezing oocytes and embryos of 222 
agricultural species (especially the pig) is difficult. It has been established for example, that both 223 
porcine oocytes and embryos are particularly susceptible to cellular damage by freezing and some 224 
trials have reported subsequent blastocyst development rates as low as 5% [51]. Difficulties associated 225 
with oocyte and embryo vitrification in the porcine model are primarily due to their high intracellular 226 
lipid content [30]; the relative abundance of lipid droplets, particularly in 1-8 cell stage porcine 227 
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embryos, makes them exceptionally challenging to work with under a microscope as the lipid bilayers 228 
darken the embryos, thus hindering observation of signs of fertilisation success (such as pronuclei) 229 
during in vitro development. Additionally, studies have indicated that separation of membrane lipids 230 
when freezing impacts post-thaw viability [52]. Hazel (1995) describes a threshold level, defined by 231 
the intracellular lipid composition, below which cell membrane function is weakened due to a phase 232 
transition that occurs in membrane fats [53]. The temperature at which this lipid phase transition 233 
takes place, is inversely proportional to the amount of unsaturated fatty acids within the membrane, 234 
and hence, by altering the composition of their lipid membranes, different organisms have the ability 235 
to adjust this threshold temperature [54]. As such, Hazel & Williams (1990) explain that, the ability of 236 
cells to survive at low temperatures is partly due to the increase in the ratio of unsaturated fatty acids 237 
within the cell membrane [55]. 238 
 239 
As such, obtaining viable 8- to 16- cell embryos that survive freezing is extremely challenging [30]. 240 
However, many studies have been conducted which aim to improve prospects of porcine embryo 241 
cryopreservation and, fortunately, some have had considerable success. For example, the application 242 
of hydrostatic pressure, prior to vitrification has been shown to improve blastocyst survival rates post 243 
warming, to over 10% [51]. Similarly, another study by Li and colleagues showed that embryo 244 
treatment with trypsin or embryo exposure to a solution of high osmolality, could eradicate the lipid 245 
layer in porcine embryos that are produced in vitro [56]. This was significant as the implementation of 246 
this method meant that embryos could be centrifuged without prior micromanipulation (to deplete 247 
the lipid bilayer) with only minimal damage to the zona pellucida [56]. Further studies have 248 
demonstrated that the critical temperature at which damage caused to cells is no longer reversible is 249 
at 15°C [30]. Furthermore, Men et al. (2011) demonstrated that disrupting the lipid bilayers via 250 
micromanipulation and then centrifuging embryos prior to vitrification had a positive outcome on 251 
survival post warm [57]. They also demonstrated that, using this approach, vitrification in a closed-252 
system was as successful as using open pulled straws, which was a major step forward in porcine 253 
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embryo cryopreservation [57]. Furthermore, Berthelot et al., (2000) revealed that an ultra-rapid open 254 
pulled straw can be used as a vitrification device for fast cooling of unhatched porcine blastocysts [58], 255 
while Galeati et al., (2011) noted low survival rates post thaw for porcine oocytes vitrified using the 256 
open Cryotop system [59]. 257 
 258 
Whilst not as sensitive as pig embryos, cow embryos are also sensitive to cooling injury at very low 259 
temperatures and initially only a few studies revealed that 8- and 16-cell embryos survived vitrification 260 
at 0°C [30]. Polge and Willadsen also demonstrated that blastocysts were better adapted to withstand 261 
cooling when compared to 8- and 16- cell embryos or even morulae, which has led scientists to focus 262 
most of their attention to vitrifying embryos at only the blastocyst stage [30]. It is important to note 263 
that there has been some evidence in the literature that flushed cattle embryos produced in vivo 264 
exhibit differences in their cryopreservation properties when compared to their in vitro fertilised 265 
counterparts (oocytes aspirated either from ovaries obtained from a slaughter house or by ovum pick 266 
up following super stimulation). Specifically, Stachecki and Wiemer (2007) note that, in comparison to 267 
their in vivo produced counterparts, bovine embryos that are developed in vitro are more sensitive to 268 
cooling [60]. The definitive cause for this is still unclear, however one reason for may be due to the 269 
metabolic differences prevalent during preimplantation development (from oocyte to hatched 270 
blastocyst) of bovine embryos based on how they were developed (in vivo or in vitro) [61]. 271 
 272 
Methods of vitrification of bovine embryos have significantly progressed in recent years; specifically, 273 
a study by Park and colleagues showed that an electron microscopy grid could be used as an effective 274 
vitrification container (instead of traditional straws), to achieve high embryo survival rates when 275 
vitrifying bovine blastocysts [62]. In another study, Mucci and colleagues compared embryo survival 276 
(defined by blastocyst hatching rate) for bovine embryos that were either vitrified or slow-frozen, and 277 
found a significant positive skew towards vitrification (43% survival rate for vitrified embryos, 278 
compared to 12% for slow-frozen embryos) [63]. Similarly, another comparative study noted that, 279 
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whilst there might be slight differences between using fresh and vitrified oocytes for IVF, for nuclear 280 
transfer experiments with cultured fibroblast cells, use of vitrified oocytes resulted in better 281 
embryonic development [64]. Additionally, a review by Dalvit and colleagues indicated that 282 
vitrification of in vitro matured bovine oocytes and embryos was successful, with no significant 283 
differences being observed between vitrified-warmed and fresh oocytes, with respect to both survival 284 
and embryonic development [65]. Additionally, no significant oocyte morphological differences were 285 
found following oocyte vitrification-warming using the Cryoptop method and open-pulled straws [66]. 286 
 287 
In comparison to bovine embryos, studies suggest that cryopreservation of ovine (sheep) embryos is 288 
relatively easier, primarily because the stage of development at which embryos are frozen is not 289 
detrimental to post thaw success rates; embryos at the 1-cell, 2-cell and blastocyst stages have all 290 
been viable after cooling at temperatures as low as 0°C [30]. However, findings demonstrated that 291 
comparatively, slow-freezing with ethylene glycol was still more successful than vitrification [67]. In 292 
the hope of developing vitrification techniques for ovine oocytes, Mullen and Fahy addressed some 293 
issues associated with the approach, which included changes in levels of messenger RNA and injury to 294 
the cytoskeleton of cells [51]. Whilst these are significant issues, some scientists have been successful 295 
in obtaining blastocyst development rates of at least 10% post-warm [51] and better success rates 296 
with using open pulled straws, for vitrification of sheep embryos, has been demonstrated more 297 
recently [68][69]. Additionally, the first successful vitrification (using a cryoloop) of sheep oocytes at 298 
the germinal vesicle stage was reported in 2013 by Moawad and colleagues, and since then, 299 
techniques for ovine oocyte vitrification have been evolving [70]. One particular challenge pertaining 300 
to mammalian oocyte cryopreservation is their extremely high cellular volume when compared to 301 
other cell types; this makes them extremely sensitive and even more susceptible to intracellular ice 302 
formation during the process of cryopreservation due to a lower surface-to-volume ratio [71]. Other 303 
factors that make oocyte cryopreservation more challenging include the presence of the zona 304 
pellucida and the decreased permeability of oocyte plasma membranes, both of which can hinder the 305 
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movement of water and cryoprotectants in and out of the oocyte [72]. Fertilisation however, alters 306 
many of these parameters and hence, embryos are generally less challenging to cryopreserve [73].  307 
 308 
As discussed previously, apart from the use of vitrification in achieving successful IVP in breeding 309 
livestock, cryopreservation also has potential to save the fate of certain endangered species and 310 
ingenious animal breeds [74]. In order to achieve this, it is important to be able to successfully 311 
preserve primordial follicles (the main source of female gametes) of these species by slow-freezing or 312 
fast-cooling. Gathering sufficient ovarian tissue (whole ovaries, ovarian cortical tissue or isolated 313 
follicles) from endangered species can however be a significantly limiting factor and hence, many farm 314 
and domestic animals are used as models to optimise cryopreservation techniques [75]. Specifically, 315 
domestic livestock, cats, dogs and capuchin monkeys are commonly used as models to enhance our 316 
current understanding of reproductive physiology and species-specific differences in non-domestic 317 
ungulates, wild felids, rare canid breeds, and new world primates respectively [74]. Thus, Leibo and 318 
Songsasen discuss how using these species as models to study cryopreservation and hence preserve 319 
their genetic material, could pave the way to potentially eliminate the risk of extinction in endangered 320 
species [76].  321 
 322 
Embryology and vitrification progress in aquaculture 323 
Many of the same challenges around the need to increase levels of production and to improve stock 324 
that are found in agriculture also exist in both fish and invertebrate aquaculture. For many aquaculture 325 
systems, there is also the additional problem that production depends on the harvest of broodstock 326 
or seed from wild populations [77]. Cryopreservation of sperm is relatively common within 327 
aquaculture, but widespread implementation of cryopreservation within the industry has however 328 
only occurred in a limited number of species, particularly salmon and turbot [77]. Work that has been 329 
done indicates that vitrification also works well in fish as an alternative to conventional 330 
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cryopreservation (e.g. [78]), but this approach has not been well explored in invertebrate systems, 331 
which represents a major opportunity for future research [79].  332 
 333 
Unfortunately, successful cryopreservation of intact fish embryos has yet to be achieved. Some 334 
success has been reported (e.g. [80]), but protocols have proved difficult to replicate (e.g. see [81]). 335 
The limiting factors for fish embryo cryopreservation include their large size, their multi-336 
compartmental nature, their high chilling sensitivity and their low membrane permeability [82]. Given 337 
these challenges, without a significant breakthrough, the successful cryopreservation of fish embryos 338 
at a commercial scale looks to be unlikely. The cryopreservation of primordial germ cells is however 339 
possible (e.g. [83][84]) and this represents a viable approach for the conservation of genetic resources 340 
and research purposes, but not for large-scale production. 341 
 342 
Future prospects 343 
Whilst there has been considerable success with vitrification of oocytes, embryos and even ovaries or 344 
ovarian tissue (particularly in humans and the mouse model), advantages of using closed systems 345 
instead of open systems, is a topic that is still widely debated in the literature; additionally, more 346 
research is required to produce more data, and importantly, more reliable results especially in 347 
agricultural animals. The development of automated devices for vitrification is potentially a huge leap 348 
forward in this regard; however, adaptation of such technology for use in agriculturally important 349 
animals such as pig and cow, whilst taking into consideration the scale of production that would be 350 
required for use in the agricultural industry, is yet to be attempted. The successful implementation of 351 
a closed, automated vitrification method could potentially revolutionise the field and would in no 352 
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Method of cryopreservation 
Slow-freezing (%) Vitrification (%) 
Pronuclear 
stage embryos 
Survival rate 89 100 
Development into blastocysts 41 52 
4-cell embryos  
Survival rate 91 98 
Development into blastocysts 84 90 
Pregnancies 51 53 
Sample Parameter 
Method of vitrification 
CryoTip™ (closed) (%) Cryotop (open) (%) 
Blastocysts 
Survival rate 93 97 
Pregnancies 51 59 
Deliveries 48 51 
 570 
Table 1: Summary of results obtained from [21]; comparison of slow-freezing versus vitrification, and 571 
the CryoTip™ (closed) versus Cryotop (open) systems. 572 
 573 
 574 
  575 
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Figure 1: Comparison of rates of ice crystal formation between slow-freezing (left) and 576 
vitrification (right): figure illustrates that during slow-freezing, water flows out of cells due to 577 
extracellular ice crystal formation, thus causing mechanical damage to the cell structure. In 578 
contrast, during vitrification, cells are inserted into vitrification medium of high viscosity, 579 
which prevents extracellular ice crystallisation and hence, cells remain intact. In both 580 
instances, cryoprotectants prevent intracellular ice crystallisation. 581 
  582 
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Figure 1 583 
Initial cell 
Before cooling 
Cell inserted into 
freezing medium 
         -5℃ 
Cell inserted into 
vitrification medium 
             -5℃ 
Water flows out of cell 
due to extracellular ice 
crystal formation 
Damage to cell, 
extracellular ice crystals form 
-196℃ 
Cell remains intact, ‘’glassy’’ 
layer forms, no ice crystals 
-196℃ 
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